CancerNetwork Members: Login | Register
 

 
NEWS
Ovarian Cancer | Page 5 - Cancer Network
www.cancernetwork.com - 12/15/11
Ovarian Cancer Staging
emedicine.medscape.com - 10/26/11
Small Study Shows Promise of a Vaccine for Metastatic Breast and Ovarian Cancer - Cancer Network
www.cancernetwork.com - 11/10/11
 
PRACTICE GUIDELINES
Guide to Clinical Preventive Services, 2010-2011: Section 2
www.ahrq.gov -
National Guideline Clearinghouse | Hereditary breast and ovarian cancer syndrome.
www.guidelines.gov -
National Guideline Clearinghouse | PET imaging in ovarian cancer: recommendations.
www.guidelines.gov -
 
JOB LISTINGS

Post a job

Powered by SearchMedica Jobs
 
FOR PATIENTS
Breast cancer - References - Genetics Home Reference
ghr.nlm.nih.gov - 1/9/12
CTNNB1 - catenin (cadherin-associated protein), beta 1, 88kDa - Genetics Home Reference
ghr.nlm.nih.gov - 1/9/12
Reproductive system - Genetics Home Reference
ghr.nlm.nih.gov - 1/9/12

 

Order Your Copy!
(2010, 13th Edition)

 


 

Please allow 3 – 4 weeks to ship
 
CONNECT WITH US
Become a fan on
Facebook
Add us on
Google Plus
Follow us on
Twitter
Sign up for our
Newsletters
Subscribe to our
RSS Feed


Ovarian Cancer
 
FEATURED ARTICLE

 

 
Ovarian cancer kills roughly 16,000 women each year. While the
disease has traditionally been treated with surgery and chemotherapy,
new targeted therapies show promise.
 
This week our authors discuss and debate the new treatment
approaches, including the merits of personalized medicine.
 
MORE FEATURES
January 19, 2012
A Step Forward Toward Better Characterization of Ovarian Cancer
A new study has made a step forward toward better characterization of sporadic ovarian tumors by identifying their DNA repair protein expression profile. More »
December 15, 2011
Ovarian Cancer
Despite the fact that it is highly curable if diagnosed early, ovarian cancer causes more mortality in American women each year than all other gynecologic malignancies combined. More »
November 10, 2011
Small Study Shows Promise of a Vaccine for Metastatic Breast and Ovarian Cancer
Breast and ovarian cancer patients with limited tumor burden and minimal prior chemotherapy appear to have benefited from a novel vaccine. More »
October 12, 2011
Large-Scale Sequencing Study Identifies BRIP1 as an Ovarian Cancer Risk Gene
The mining of whole genomes from 656 Icelanders with ovarian cancer and the comparison of these genomes to 41,675 control genotyped Icelanders has led to the identification of 16 million sequence variants that were tested for their association to ovarian cancer, one of the deadliest forms of cancer among women. More »
September 22, 2011
Use of Fluorescence Imaging During Cytoreductive Surgery Could Improve Outcomes in Ovarian Cancer
To improve staging, debulking, and prognosis in cytoreductive surgery, researchers in the Netherlands and Germany have developed a fluorescence imaging technique to visualize ovarian tumors. More »
Showing 1 - 5 of 168 results.
Page of 34
First Previous Last
 
CLINICAL TRIALS
A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant (Montanide ISA-51) as Consolidation Following Optimal Debulking and Systemic Chemotherapy for Women With Advanced Stage Ovarian, Tubal or Peritoneal Cancer - Full Text View - ClinicalTrial
www.clinicaltrials.gov -
Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer - Full Text View - ClinicalTrials.gov
www.clinicaltrials.gov -
Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer - Full Text View - ClinicalTrials.gov
www.clinicaltrials.gov -
OVATURE (OVArian TUmor REsponse) Study: A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer - Full Text View - ClinicalTrials.gov
www.clinicaltrials.gov -
Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin - Full Text View - ClinicalTrials.gov
www.clinicaltrials.gov -
 
MEDLINE
Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype.
pubmed.gov - 11/28/11
Although it is well known that ovarian endometriosis occasionally gives rise to ovarian cancers with specific histology such as endometrioid and clear cell carcinomas, its etiology is not fully understood. We have shown that a stressful microenvironment within the endometriotic cyst may lead to cancer development by inducing unique gene expressions, which potentially serves as a molecular marker for treatment modality. In this review, by referring to other articles in this field, we explore how the carcinogenic microenvironment affects the phenotype and gene expression of a cancer, and how we can develop new treatment based on this concept.
Ovarian cancer screening and mortality.
pubmed.gov - 10/12/11
Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists.
pubmed.gov - 11/1/11
Variably-spliced prolactin receptors (PRLRs) and PRL are expressed by the ovarian cancer cell lines, TOV-112D, OV-90 and TOV-21G. Incubation in the PRLR antagonists, G129R- or S179D-PRL, or anti-PRL reduced cell number, indicating a functional autocrine PRL growth loop. Added PRL promoted, and the antagonists decreased, cell migration. When cells were stressed, added PRL decreased apoptosis and increased survival, and the antagonists had the opposite effect. Cells expressing higher long:short PRLR ratios had increased growth, survival and migration in response to PRL. Results suggest that PRLR antagonists may be therapeutically beneficial in ovarian cancer.
Trabectedin and ovarian cancer (continued).
pubmed.gov - 10/1/11
Early detection of ovarian cancer: if only we had a "Pap smear" for this disease.
pubmed.gov - 10/1/11



 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 
 
FROM PHYSICIANS PRACTICE
Tax Schemes Every Physician Should Avoid
Ike Devji, JD, January 31, 2012
The next 60 days marks the final push to sell physicians across the United States tax plans of both good and questionable value.
Boosting Collections at Your Medical Practice: Whose Job Is It?
P.J. Cloud-Moulds, January 28, 2012
Embrace the relationship between your billing company and your medical practice staff.
Managing Difficult Medical Practice Employees
Shelly K. Schwartz, January 27, 2012
Tips for transforming immature staff members into great employees.
Prevent Physician Distraction When Using mHealth Technology
Aubrey Westgate, January 25, 2012
As more and more physicians use handheld mobile technology in their day-to-day work, some critics are raising concerns about “distracted doctoring.”
Can That Applicant Do the Job at Your Medical Practice?
Karen Zupko, January 25, 2012
If like many communities, yours has significant numbers of non-English speaking people with whom neither you nor your staff are able to converse, your practice is at a serious disadvantage.
 
MOST POPULAR
 
COMMENTS